Biocartis (Euronext Bxl: BCART) is an innovative MDx company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Its proprietary MDx Idylla™ platform, launched in Sept 2014, is a fully automated sample-to-result, real-time Polymerase Chain Reaction system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting.
Included in Export Interest Directory? Yes
Business Needs: Distributor/Agent/Representative